Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

Interim Management Statement

18 May 2023 10:23

RNS Number : 8917Z
Mandarin Oriental International Ltd
18 May 2023
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

18th May 2023 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2023.

 

The Group recorded an underlying profit in the first quarter of 2023, driven by improved performance from both the Group's owned hotels and its management business. RevPAR grew substantially in Asia compared to last year, as the region benefitted from the removal of travel restrictions. As a result, the Group's owned hotels saw a significantly improved performance, particularly in Hong Kong, Tokyo, and Bangkok. In the rest of the world, our hotels were also able to achieve a higher RevPAR compared to both last year and 2019, driven by strong rates.

 

The first quarter saw progress on a number of hotel developments. In January, the Group announced a new management contract for a luxury beach resort in Mallorca, Spain, scheduled to open by the end of 2024. In February, after three years' work, the Emirates Palace hotel in Abu Dhabi was rebranded as Emirates Palace Mandarin Oriental, Abu Dhabi. In March, Mandarin Oriental, Singapore, closed for a substantial renovation; it is expected to reopen in September 2023.

 

As a result of improved trading conditions, the Group generated underlying earnings before interest, tax, depreciation, and amortisation ('EBITDA') of US$30 million, a substantial increase from the EBITDA loss of US$1 million in the first quarter of 2022. Owned hotels reported an EBITDA of US$19 million, with almost all hotels delivering increased financial performance. The management business saw significant growth and generated higher fees, with hotels, particularly in Hong Kong and Mainland China, contributing to an EBITDA of US$7 million. Unaudited underlying profit in the first quarter was US$3 million, much improved from an underlying loss of US$26 million in 2022.

 

The Group's redevelopment project in Causeway Bay, Hong Kong, formerly the site of The Excelsior hotel, is ongoing, in line with our budget, and is expected to complete in early 2025.

 

Consolidated net debt as at 31st March 2023 reduced to US$311 million (US$376 million at 31st December 2022). The Group's liquidity position remains robust, with US$453 million in available committed debt facilities and US$306 million of cash reserves. Gearing was 6% of adjusted shareholders' funds.

 

On 2nd May 2023, the Company announced that Laurent Kleitman would replace James Riley as Group Chief Executive of Mandarin Oriental International Limited with effect from 1st September 2023.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley

(852) 2895 9288

Matthew Bishop

(852) 2895 9288

 

Brunswick Group Limited

William Brocklehurst

(852) 5685 9881

 

This and other Group announcements can be accessed online at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKVLBFXELLBBB
Date   Source Headline
1st Feb 20177:00 amRNSTotal Voting Rights
9th Nov 20169:11 amRNSInterim Management Statement
30th Sep 201610:54 amRNSTotal Voting Rights
30th Sep 201610:53 amRNSDirector Declaration
29th Sep 201611:35 amRNSDirector/PDMR Shareholding
28th Sep 201611:57 amRNSDirector/PDMR Shareholding
28th Sep 201611:25 amRNSDividend
26th Sep 201610:38 amRNSBlock listing Interim Review
1st Sep 201610:32 amRNSDirector Declaration
22nd Aug 201611:44 amRNSDirector Declaration
3rd Aug 201610:24 amRNSDirector Declaration
1st Aug 201610:39 amRNSDirector Declaration
28th Jul 201610:09 amRNSHalf Yearly Results - 6 Months Ended 30 June 2016
30th Jun 201611:01 amRNSNotice of 2016 Half-Yearly Results
13th Jun 201610:11 amRNSDirectorate
13th May 201610:11 amRNSDirector/PDMR Shareholding
4th May 20162:26 pmRNSNon-Routine Resolutions submitted via NSM
4th May 20162:17 pmRNSResult of AGM
4th May 201612:34 pmRNSInterim Management Statement
28th Apr 20161:11 pmRNSDirector Declaration
28th Apr 201612:17 pmRNSHolding(s) in Company
27th Apr 201610:38 amRNSDividend
7th Apr 201610:17 amRNSAnnual Financial Report
29th Mar 201610:38 amRNSBlocklisting Interim Review
17th Mar 201611:11 amRNSDirector/PDMR Shareholding
7th Mar 201610:40 amRNSDirector/PDMR Shareholding
4th Mar 201610:59 amRNSDirector/PDMR Shareholding
3rd Mar 20169:07 amRNS2015 Preliminary Announcement of Results
1st Feb 20169:24 amRNSDirector Declaration
1st Feb 20169:23 amRNSNotice of 2015 Final Results
6th Jan 20167:00 amRNSMandarin Oriental to Acquire Boston Hotel
24th Dec 20157:56 amRNSDirector/PDMR Shareholding
23rd Dec 201510:27 amRNSDirector/PDMR Shareholding
30th Nov 20159:35 amRNSDirector Declaration
26th Nov 20159:18 amRNSDirectorate Change
26th Nov 20159:15 amRNSJames Riley to Succeed Edouard Ettedgui as GroupCE
26th Nov 20159:10 amRNSDirectorate Change
4th Nov 20159:16 amRNSInterim Management Statement
2nd Oct 201510:47 amRNSDirector/PDMR Shareholding
30th Sep 201511:04 amRNSDirector/PDMR Shareholding
30th Sep 201510:14 amRNSDividend
30th Sep 201510:12 amRNSTotal Voting Rights
25th Sep 201511:09 amRNSDirector/PDMR Shareholding
25th Sep 201510:15 amRNSBlocklisting Interim Review
23rd Sep 201510:54 amRNSDirector/PDMR Shareholding
3rd Aug 201511:20 amRNSDirector Declaration
30th Jul 201510:16 amRNSDirectorate Change
30th Jul 201510:07 amRNSHalf Yearly Results - 6 months ended 30 June 2015
2nd Jul 201510:19 amRNSNotice of 2015 Half-Yearly Results
30th Jun 201510:15 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.